BrainQ named "Best New Technology Solution – Therapeutic” in the 2024 MedTech Breakthrough Awards

By: BrainQ team

Company Updates

Awards recognize the ‘BREAK THROUGH’ companies, people, platforms and products in the health, fitness, and medical technology industries today.

[Jerusalem, IL], May 9, 2024 — BrainQ Technologies, a pioneering company at the forefront of brain longevity therapeutics, proudly announces that it has been awarded "Best New Technology Solution – Therapeutic” in the prestigious MedTech Breakthrough Awards 2024.

This recognition underscores our unwavering dedication to pioneering brain longevity therapeutics, particularly in the realm of stroke recovery. Through our innovative solutions, we are committed to empowering patients, enabling them to regain independence and markedly improving their quality of life.

Celebrating the forefront of innovation in health, fitness, and medical technology, the MedTech Breakthrough Awards recognize outstanding achievements across companies, individuals, platforms, and products that define breakthrough advancements in these industries today.

For comprehensive insights and the full roster of awardees, explore the complete list here.


About the Medtech Breakthrough Awards

The MedTech Breakthrough Awards celebrate innovation in healthcare technology, recognizing advancements in telehealth, electronic health records, mHealth, and patient privacy. With a focus on disrupting and innovating the medical technology industry, these awards highlight breakthroughs that are transforming patient care and outcomes.

In a year marked by unprecedented growth and momentum in digital health, the MedTech Breakthrough Awards provide a platform for companies to stand out in the HealthTech crowd. With record-breaking funding and a surge of companies entering the public sphere, these awards recognize excellence and creativity in driving the future of healthcare technology forward.


About BrainQ

BrainQ is a pioneering brain longevity therapeutics company. The company has received an FDA Breakthrough Device Designation for its first product for Stroke disability.